Immunovant
IMVT
$25.39
Share price
-3.86%
Change (1 day)
22.78%
Change (1 year)
Categories
Market capitalization of Immunovant (IMVT)
Market cap: $3.70 Billion
As of June 2024 Immunovant has a market cap of $3.70 Billion. This makes Immunovant the world's 3139th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Immunovant from 2019 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $3.70 B | -39.15% |
| 2023 | $6.09 B | 165.79% |
| 2022 | $2.29 B | 134.02% |
| 2021 | $0.97 B | -78.33% |
| 2020 | $4.52 B | 421.29% |
| 2019 | $0.86 B |
End of Day market cap according to different sources
On Jun 1st, 2024 the market cap of Immunovant was reported to be:
$3.70 Billion
$3.70 Billion
$3.70 Billion
$3.70 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.60 B | -83.65% | 🇺🇸 USA |